Archean Chemical Industries Limited has informed regarding subscription to the rights issue of equity shares of its wholly owned subsidiary, Acume Chemicals Private Limited ( Acume Chemicals ).
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Archean Chemical Industries Limited is subscribing to a rights issue of its wholly owned subsidiary, Acume Chemicals Private Limited, investing up to Rs. 170 crore in one or more tranches. The shares will be subscribed at face value of Rs. 10 per share, and the company will maintain its 100% stake in the subsidiary post-subscription. The stated objectives include strengthening Acume Chemicals' capital base for business expansion, improving capacity utilization and product mix, and reducing external borrowings. Acume Chemicals operates in the Bromine Derivatives business and reported turnover of Rs. 8,111.53 lakhs for FY2024-25, up significantly from Rs. 2,717.86 lakhs in FY2023-24. The transaction constitutes a related party transaction but is being undertaken on an arm's length basis.
This investment of Rs. 170 crore represents a significant capital commitment to support subsidiary growth and deleverage the balance sheet. While maintaining 100% ownership, the parent is funding Acume Chemicals' expansion and debt reduction, which could benefit consolidated financials long-term.